Paul Schimmel - 20 Sep 2021 Form 4 Insider Report for aTYR PHARMA INC (ATYR)

Role
Director
Signature
Nancy E. Denyes, Attorney-in-Fact
Issuer symbol
ATYR
Transactions as of
20 Sep 2021
Net transactions value
+$2,000,000
Form type
4
Filing time
22 Sep 2021, 20:19:41 UTC
Previous filing
20 May 2021
Next filing
28 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LIFE Common Stock Purchase $2,000,000 +250,000 +8651% $8.00 252,890 20 Sep 2021 Direct F1
transaction LIFE Common Stock Gift $0 -250,000 -99% $0.000000 2,890 20 Sep 2021 Direct
transaction LIFE Common Stock Gift $0 +250,000 +58% $0.000000 679,143 20 Sep 2021 See Footnote F2
holding LIFE Common Stock 113,023 20 Sep 2021 See Footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares purchased in an underwritten public offering at a public offering price of $8.00 per share.
F2 These shares are owned directly by Schimmel Revocable Trust U/A Dtd 9/6/2000. The Reporting Person and his spouse are trustees of the Schimmel Revocable Trust U/A Dtd 9/6/2000.
F3 These shares are owned directly by Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. The Reporting Person is the sole owner of the Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel.